An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations JOVE-J VIS EXP
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma Front Immunol
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? Int J Mol Sci
An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma Nat Commun
Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018) CANCER MED-US
G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy Front Immunol
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials Haematologica
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis J Immunother Cancer